Mupirocin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons
Conditions:   HIV Infections;   Staphylococcal InfectionsInterventions:   Drug: Mupirocin (Bactroban) 2%; hexachlorophene (pHisoHex) 3%;   Drug: PlaceboSponsors:   Uniformed Services University of the Health Sciences;   Infectious Diseases Clinical Research Program;   National Institute of Allergy and Infectious Diseases (NIAID);   US Military HIV Research ProgramActive, not recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2008 Category: Research Source Type: clinical trials

Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons
Conditions:   HIV Infections;   Staphylococcal InfectionsInterventions:   Drug: Mupirocin (Bactroban) 2%; hexachlorophene (pHisoHex) 3%;   Drug: PlaceboSponsors:   Uniformed Services University of the Health Sciences;   Infectious Diseases Clinical Research Program;   National Institute of Allergy and Infectious Diseases (NIAID);   US Military HIV Research ProgramActive, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2008 Category: Research Source Type: clinical trials